Similar articles

• The effects of polycystic ovary syndrome on gestational diabetes mellitus.

  Aktun HL, Yorgunlar B, Acet M, Aygun BK, Karaca N. Aktun HL, et al. Gynecol Endocrinol. 2016;32(2):139-42. doi: 10.3109/09513590.2015.1101438. Epub 2015 Oct 19. Gynecol Endocrinol. 2016. PMID: 26479686
• Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study.

  Bond R, Pace R, Rahme E, Dasgupta K. Bond R, et al. Diabet Med. 2017 Dec;34(12):1684-1695. doi: 10.1111/dme.13444. Epub 2017 Sep 1. Diabet Med. 2017. PMID: 28782842
• Reproductive endocrinology: adverse pregnancy outcomes in polycystic ovary syndrome.

  Glover J. Glover J. Nat Rev Endocrinol. 2011 Nov 8;8(1):2. doi: 10.1038/nrendo.2011.194. Nat Rev Endocrinol. 2011. PMID: 22064500 No abstract available.
• Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline.

  Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, et al. Fertil Steril. 2017 Sep;108(3):426-441. doi: 10.1016/j.fertnstert.2017.06.026. Fertil Steril. 2017. PMID: 28865539 Review.
• Role of metformin in patients with polycystic ovary syndrome: the state of the art.

  Palomba S, Falbo A, Russo T, Orio F, Tollino A, Zullo F. Palomba S, et al. Minerva Ginecol. 2008 Feb;60(1):77-82. Minerva Ginecol. 2008. PMID: 18277354 Review.